Status:
COMPLETED
Nebulized Dexmedetomidine as a Premedication for Gastrointestinal Endoscopy in Pediatric Patients
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Pediatric
Sedation
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
This study aims to demonstrate that the application of nebulized dexmedetomidine to patients during pediatric upper gastrointestinal endoscopic procedures will significantly reduce the gag reflex and ...
Detailed Description
Due to the intolerance of pediatric patients to the insertion of the endoscopic probe during upper gastrointestinal procedures, sedation and analgesia are required. In this patient group, the reflex t...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I and II
- 2 to 17 years of age,
- Patient undergoing in Upper Gastrointestinal Endoscopy
Exclusion
- Patients with heart disease
- Patients with mental-motor retardation
- Patients with abnormal upper respiratory tract
- Patients with a history of asthma
- Patients with upper respiratory tract history in the last 4 weeks
- Patients with severe sleep apnea on polysomnography
- ASA \>III patients
- Patients with drug allergies
Key Trial Info
Start Date :
January 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06218797
Start Date
January 31 2024
End Date
August 30 2024
Last Update
October 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayis University
Samsun, Atakum, Turkey (Türkiye), 55139